Overview

Brought to you by DIA in cooperation with

Microsoft

Biopharmaceutical companies clearly express the desire to adopt digital technologies in an effort to accelerate clinical development. COVID-19 has served to underscore the need for digitalization for business continuity and virtual data access, for employees, collaboration partners and patients. This webinar will share insights gained from more than 250 biopharma executives on implementation and adoption of digital technologies in biopharma R&D across four areas – strategy, value, progress and barriers to adoption. We’ll share insights from these executives as well as our observations and experience working with life sciences companies as well as companies in other industries prove that change will happen.

Featured topics

Digital strategy
Hurdles to adoption of digital capabilities
Digital technologies

Who should attend?

Professionals who work in the area of:

Learning objectives

Upon completion of the webinar, participants will have a better understanding of:

How the biopharmaceutical industry evaluates their maturity in adopting digital capabilities
How digital can help R&D organizations achieve their strategic imperatives
What the most common barriers are to digital adoption in biopharma R&D
What steps R&D organizations can take to help ensure they are getting scaling the right digital capabilities and realizing the most value from these capabilities

Continuing Education Credits are not available for this event.

Have an account?

What’s the Key to Digital Transformation in Biopharma R&D?

Overview

Featured topics

Who should attend?

Learning objectives

Be informed and stay engaged.